Dong Won Baek
Overview
Explore the profile of Dong Won Baek including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
191
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lee J, Cho H, Kim J, Baek D, Choi H, Ham J, et al.
Clin Lab
. 2025 Feb;
71(2).
PMID: 39967548
Background: This study retrospectively analyzed the prognostic impact of transfusion burden in patients with lower-risk myelodysplastic syndrome (LR-MDS) and the outcomes of each treatment option. Methods: Data on 168 patients...
2.
Cho H, Baek D, Kim J, Jang Y, Lee Y, Moon J, et al.
Acta Haematol
. 2025 Jan;
1-14.
PMID: 39799934
Introduction: This study aimed to analyze the survival outcomes and adverse events (AEs) associated with the long-term use of tyrosine kinase inhibitors (TKIs) and to assess health-related quality of life...
3.
Lee J, Kim D, Cho H, Moon J, Sohn S, Shin H, et al.
Korean J Intern Med
. 2025 Jan;
40(1):124-134.
PMID: 39778531
Background/aims: To determine the effectiveness of tyrosine kinase inhibitor (TKI) plus reduced-intensity therapy in adult patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph-positive ALL), this retrospective study compared...
4.
Lee J, Han M, Baek D
Am J Case Rep
. 2025 Jan;
26():e945435.
PMID: 39748486
BACKGROUND Simultaneously occuring diffuse large B-cell lymphoma (DLBCL) and Hodgkin lymphoma (HL) is extremely rare. Generally, patients with CD20-positive DLBCL receive rituximab, cyclophosphamide, vincristine, doxorubicin, prednisone (R-CHOP) regimen, while those...
5.
Lee Y, Jang Y, Lee J, Cho H, Moon J, Sohn S, et al.
Support Care Cancer
. 2024 Oct;
32(11):715.
PMID: 39377915
Background: Using granulocyte colony-stimulating factor (G-CSF) after completing chemotherapy reduces the duration of neutropenia and infections. However, the efficacy and safety of prophylactic pegfilgrastim in acute lymphoblastic leukemia (ALL) patients...
6.
Nguyen H, Le T, Lee D, Cho H, Lee J, Sohn S, et al.
In Vivo
. 2024 Jun;
38(4):1740-1749.
PMID: 38936885
Background/aim: To date, therapeutic options for T-cell acute lymphoblastic leukemia (T-ALL) remain very limited. This study evaluated the efficacy of monotherapies and combination therapies including a selective BCL-2 inhibitor for...
7.
Sohn S, Lee J, Jang Y, Lee Y, Na J, Cho H, et al.
Expert Rev Hematol
. 2024 May;
17(7):353-359.
PMID: 38755522
Introduction: The treatment outcomes for Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL) have improved with various tyrosine kinase inhibitors (TKIs) and bispecific T-cell engagers. Although allogeneic stem cell transplantation (allo-SCT) is...
8.
Baek D, Song G, Lee H, Do Y, Lee J, Yhim H, et al.
Front Oncol
. 2024 May;
14:1380492.
PMID: 38715775
Background: Elderly patients diagnosed with diffuse large B-cell lymphoma (DLBCL) undergoing reduced intensity R-CHOP therapy are at a heightened risk of acquiring infections, notably coronavirus disease 2019 (COVID-19) infection. This...
9.
Kim J, Le T, Lee D, Nguyen H, Cho H, Sohn S, et al.
In Vivo
. 2023 Dec;
38(1):372-379.
PMID: 38148060
Background/aim: This study evaluated the possibility of clinical use of circulating-tumor DNA (ctDNA) as a biomarker to determine up-front autologous stem cell transplantation (auto-SCT) for patients with high-risk diffuse large...
10.
Baek D, Moon J, Lee J, Kang K, Lee H, Eom H, et al.
Blood Cancer J
. 2023 Jun;
13(1):95.
PMID: 37365207
This study aimed to identify the benefits of autologous-stem cell transplantation (auto-SCT) and allogeneic-SCT (allo-SCT) in patients with aggressive T-cell lymphomas to aid in the selection of transplantation type in...